Cargando…
Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome
BACKGROUND: Hepatorenal syndrome type 1 (HRS-1), a form of acute kidney injury (AKI) in cirrhosis, has a median survival of days to weeks if untreated. The impact of reduction in AKI stage on overall survival in cirrhosis, independent of HRS reversal, is unclear. METHODS: The Randomized, placEbo-con...
Autores principales: | Wong, Florence, Boyer, Thomas D, Sanyal, Arun J, Pappas, Stephen C, Escalante, Shannon, Jamil, Khurram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473801/ https://www.ncbi.nlm.nih.gov/pubmed/30887050 http://dx.doi.org/10.1093/ndt/gfz048 |
Ejemplares similares
-
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute‐on‐chronic liver failure
por: Wong, Florence, et al.
Publicado: (2022) -
The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome
por: Velez, Juan Carlos Q., et al.
Publicado: (2023) -
Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial
por: Karvellas, Constantine J., et al.
Publicado: (2023) -
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT‐0401 and REVERSE randomised clinical studies
por: Sanyal, A. J., et al.
Publicado: (2017) -
Acute kidney injury and hepatorenal syndrome in cirrhosis
por: Gupta, Kapil, et al.
Publicado: (2021)